CD Bioparticles Launches Custom Latex Immunoturbidimetric Assay (LIA) Development Services to Accelerate IVD Innovation
Sep 22, 2026
CD Bioparticles launches end-to-end Custom Latex Immunoturbidimetric Assay development services for research applications.
New York, NY, United States, September 22, 2026 /MarketersMEDIA/ -- With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expansion of its diagnostic capabilities with the launch of its end-to-end Custom Latex Immunoturbidimetric Assay development services. These services offer full-spectrum assay customization ranging from particle conjugation to fully optimized kit assembly, and can help researchers and diagnostic developers to streamline IVD reagent manufacturing and clinical biomarker quantification.
The immunoturbidimetry method is an analytical technique combining liquid-phase precipitation reactions with optical instruments and automated analysis. However, due to issues relating to the size and quantity of antigen-antibody complexes, the immunoturbidimetry has low sensitivity and a narrow detection range. This has led to the development of the latex immunoturbidimetric assay (LIA). This technique uses latex microparticles that are coated with specific antibodies or antigens.
When these particles encounter the target analyte in a sample, they form specific aggregates through antigen-antibody interactions. The aggregation of these particles increases the scattering intensity or absorbance of the latex suspension. This increase is quantitatively correlated with the concentration of the target analyte in the sample. Turbidity measurements are performed using a biochemical analyser, and the entire analytical process takes only a few minutes. Compared to traditional immunoturbidimetric methods, this method offers significantly higher sensitivity, with detection limits as low as ng/mL or pg/mL.
CD Bioparticles has extensive experience in assay solutions and now offers custom services to help researchers and diagnostic product developers develop latex immunoturbidimetric assays. The company's service portfolio ranges from custom conjugation to the optimization of complete immunoturbidimetric assays. The company provides custom-made, carboxyl-functionalized polystyrene microspheres that are conjugated with antigens or antibodies and come in various sizes. CD Bioparticles also offers complete kits for the quantitative detection of a wide range of biomarkers. These products feature high sensitivity, short assay times and compatibility with automated biochemical analyzers.
CD Bioparticles offers customers carboxyl-modified polystyrene microparticles in a range of sizes (from 0.07 to 0.4 μm) that are suitable for developing latex immunoturbidimetric assay reagents. CD Bioparticles' standard products feature a moderate surface carboxyl density; products with higher or lower densities are also available upon request. Additionally, CD Bioparticles can customize the conjugation of antibodies and antigens to meet specific application requirements. Through optimization, the team can ensure high conjugation efficiency while maintaining the activity of both antibodies and antigens.
CD Bioparticles also offers reagent formulation development and optimization services to help customers improve reagent stability, optimize reaction conditions and enhance detection sensitivity. The company offers performance validation services to verify key performance indicators, including linearity, sensitivity, specificity and precision, ensuring stability across different batches and under various operating conditions.
For more information about CD Bioparticles' Custom Latex Immunoturbidimetric Assay development services or to submit a project inquiry, please visit https://www.cd-bioparticles.com/services/latex-immunoturbidimetric-assay-development.html.
About CD Bioparticles
CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.
Contact Info:
Name: Richard J. Gray
Email: Send Email
Organization: CD Bioparticles
Website: https://www.cd-bioparticles.com/
Release ID: 89204007
If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release that require attention or if there is a need for a press release takedown, we kindly request that you notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or guide you through the removal process. Ensuring accurate and reliable information is fundamental to our mission.
More News
Trump Officials Eject 750,000 From Obamacare Markets, Claiming Fraud
Vice President JD Vance said the measure would save the government $2.2 billion.
New EU industry rules would damage UK, warns Burnham
The prime minister met the European Commission President during his visit to the United Nations General Assembly.
Trump Says He Supports Banning Diesel Exports to Bring Down Prices
Diesel prices have been setting records because of the war in Iran, but the oil industry say banning U.S. exports would not make the fuel cheaper.
Trump says he would back ban on diesel exports
Republicans lawmakers have put pressure on the president to curb exports as diesel prices soar to record highs in the US.
How Paramount Won Warner Bros.
After months of legal and political wrangling, the media mogul David Ellison arrived at a deal with the coalition of states seeking to block his $111 billion acquisition of Warner Bros. Discovery.
Global Oil Price Drops Below $100 a Barrel
Investors anticipated that a damaged Saudi Arabian pipeline may be close to reopening, allowing more oil from the region to reach world markets.
The A.I. Party House Where Networking Has a Dark Side
Group tech houses have proliferated across the San Francisco Bay Area in the artificial intelligence boom. One of the most prominent has also racked up an extensive police record.
Rosie O’Donnell Says ABC Delayed a Skit as It Readied Trump Suit
The network asked the comedian to hold off on the sketch, which mocked the president, when she filled in as host of “Jimmy Kimmel Live!”
The EU Just Asked Canada If We Could Be Best Buddies...Legally, And Canadians Are Responding In The Most Hilarious Way
Give me a baguette, a ciggy, and an espresso any day. View Entire Post ›
An A.I. Image of Trump Kissing a Woman Was Fake. It Spread Anyway.
Advances in artificial intelligence and the myriad ways content is shared online have made establishing authenticity even more difficult for users of social media.
How Luxury Hotels Are Turning Swag Into Covetable Fashion
Forget the branded pen. Today’s best hotel souvenirs include Frame cashmere, Off-White beach bags and corduroy caps coveted enough to sell out—because apparently checkout no longer means leaving everything behind. The post How Luxury Hotels Are Turning Swag Into Covetable Fashion appeared first on Business Traveller.
Patagonia Offers $100 to Customers Who Help Others Plan to Vote
The outdoor apparel brand, which sued the Trump administration this month, is ramping up its environmental activism before the midterm elections.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.